What are the recommended starting and maintenance doses for buprenorphine, methadone, and oral naltrexone in the treatment of opioid use disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Dosing for Opioid Use Disorder Medications

For buprenorphine, start with 8 mg on Day 1 (only when moderate withdrawal is present), followed by 16 mg on Day 2, then maintain at 16 mg daily; for methadone, start with 20-30 mg (maximum 40 mg on Day 1), then titrate to 80-120 mg daily for maintenance; for oral naltrexone, use 50 mg daily only after complete opioid detoxification. 1, 2

Buprenorphine Dosing

Induction Requirements

  • Critical timing: Administer the first dose only when objective signs of moderate opioid withdrawal appear 1
  • For short-acting opioids (heroin, morphine): Wait at least 4 hours after last use 1
  • For long-acting opioids (methadone >30 mg): Wait at least 24 hours after last use to avoid precipitated withdrawal 1
  • Use Clinical Opiate Withdrawal Scale (COWS) score >8 to confirm readiness 3

Starting Doses

  • Day 1: 8 mg sublingual 1
  • Day 2: 16 mg sublingual 1
  • Day 3 onward: Continue 16 mg daily (target maintenance dose) 1

Maintenance Dosing

  • Target dose: 16 mg daily 1
  • Effective range: 4-24 mg daily, adjusted in 2-4 mg increments 1
  • Doses above 24 mg provide no additional clinical benefit 1
  • High-quality evidence shows only doses ≥16 mg effectively suppress illicit opioid use compared to placebo 4

Administration Technique

  • Place tablets under the tongue until completely dissolved 1
  • Do not cut, chew, or swallow 1
  • No eating or drinking until fully dissolved 1
  • For doses requiring >2 tablets, place all at once or 2 at a time 1

Methadone Dosing

Initial Dosing

  • Day 1: 20-30 mg single dose (maximum 40 mg total) 2
  • Administer only when no signs of sedation/intoxication present and withdrawal symptoms evident 2
  • If withdrawal persists after 2-4 hours, may add 5-10 mg 2

Dose Titration

  • Adjust over the first week based on withdrawal control 2
  • Critical warning: Deaths occur in early treatment due to cumulative effects—titrate cautiously 2
  • Increase in 5-10 mg increments if withdrawal persists 5

Maintenance Dosing

  • Target range: 80-120 mg daily 2
  • This range achieves optimal outcomes: prevents withdrawal for 24 hours, reduces cravings, blocks euphoric effects of other opioids 2
  • Evidence shows methadone >50-65 mg daily is more effective than buprenorphine 2-8 mg daily for retention 4, 6
  • Low-dose methadone (≤40 mg) is less effective than buprenorphine 4

Special Considerations

  • Patients on methadone >30 mg are more susceptible to precipitated withdrawal when switching to buprenorphine 1
  • For conversion from buprenorphine to methadone (e.g., acute pain management): Start 30-40 mg daily 5

Oral Naltrexone Dosing

Prerequisites

  • Absolute requirement: Patient must be completely opioid-free and through withdrawal 7
  • Cannot be used in opioid-dependent patients—will precipitate severe withdrawal 7

Dosing

  • Standard dose: 50 mg daily 8
  • Must complete detoxification first, typically using buprenorphine 2-4 mg combined with clonidine, then progressive naltrexone induction over 3-5 days 7

Comparative Effectiveness

Treatment Retention

  • Methadone superior to buprenorphine for retention when flexible dosing used (RR 0.83; 95% CI 0.72-0.95) 4
  • At equivalent high doses (buprenorphine ≥16 mg vs methadone ≥85 mg), no difference in retention 4
  • Naltrexone has poorest retention—50 mg naltrexone significantly worse than both methadone 50 mg and buprenorphine 5 mg 8

Suppression of Illicit Opioid Use

  • For buprenorphine: Only doses ≥16 mg suppress illicit use better than placebo 4
  • Methadone and high-dose buprenorphine equally suppress illicit use when patients remain in treatment 4
  • Both superior to naltrexone for this outcome 8

Critical Pitfalls to Avoid

  1. Precipitated withdrawal with buprenorphine: Never give buprenorphine until clear withdrawal signs present—its high receptor affinity will displace other opioids and cause severe withdrawal 1

  2. Methadone accumulation: Methadone has a long half-life; early deaths occur from cumulative dosing—never exceed 40 mg on Day 1 2

  3. Underdosing: Low-dose buprenorphine (2-6 mg) and low-dose methadone (≤40 mg) are inadequate for most patients 4

  4. Premature naltrexone induction: Starting naltrexone before complete opioid clearance causes severe precipitated withdrawal 7

  5. Fentanyl considerations: With widespread fentanyl use, traditional buprenorphine induction may require longer waiting periods (>12 hours) due to fentanyl's lipophilicity 9

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.